COLL vs ECL
Collegium Pharmaceutical Inc (COLL) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the COLL and ECL stock pages for the full models.
Not investment advice.